NanoSense

Menu
Book an Appointment

ViruSense

PUBLIC HEALTH — VIRUSENSE

The next pandemic is not a question of if but when.

Covid-19 cost the world 6.7 million lives and $28 trillion. The lesson was clear — early detection is the only answer. ViruSense delivers real-time virus detection without the wait.
Enquire about EnviroSense

THE COST OF UNPREPAREDNESS

Coronavirus:
a lesson in unpreparedness.

The IMF raised concerns that the full cost of the pandemic will exceed $28 trillion through 2024. Governments worldwide were criticised for failing to deliver efficient detection and testing capabilities quickly enough.

6.7m

people died Jan 2020 – Dec 2022 fighting for their last breath

$28Tn

IMF projected cost of the pandemic through 2024

€115bn

potential yearly cost of Long Covid — OECD countries alone

0

real-time virus detection solutions existed at outbreak

FROM AEROTOXIC TO PANDEMIC

Early detection
is the only answer.

The WHO confirmed it: early detection is key to combating the spread of coronavirus. Yet throughout the pandemic, governments had no real-time detection capability.
The same NanoSense team that delivered the world’s first real-time organophosphate detector for aircraft recognised that their NPL-verified technology detects compounds 100 times smaller than viruses. The adaptation for virus detection commenced immediately, in collaboration with the UK’s Rosalind Franklin Institute.

Real-time detection provides real-time protection. ViruSense doesn't wait for results — it delivers them.

The Gap: No Real-Time Testing

Lateral flow and PCR tests are neither real-time nor scalable. They require samples, processing time, and cannot screen public spaces. ViruSense is the first real-time optical virus sensor.

NPL-Verified Sensitivity

The NanoSense platform already detects molecules 100 times smaller than a virus particle — at the chemical building-block level. Virus adaptation is an extension of proven technology, not a new gamble.

Rosalind Franklin Institute Collaboration

The UK’s Rosalind Franklin Institute agreed to collaborate on the ViruSense Covid virus sensor programme — providing world-class scientific validation and development support.

Another Pandemic Is Coming

Bill Gates (18/2/22): advances in medical technology should help the world do a better job of fighting it, if investments are made NOW. ViruSense is that investment.

VIRUSENSE BY NANOSENSE

Virus detection without the wait.
SARS. Influenza. Covid-19 & variants.

164 g

Weight

33 × 23 cm

Form factor

SARS · Flu · Covid

Viruses

Real-time

Time to result

UK · US · EU · JP

Patents

REAL-TIME DETECTION — REAL-TIME PROTECTION

ViruSense: deploy everywhere people gather.

Tier 1 — Immediate Deployment

Airports · Seaports · Border Control Points

Tier 2 — Scale Deployment

Hospitals · Health Centres · Railway Stations Bus & Tube Stations · Supermarkets Public Entertainment Venues & more

$2.6Bn+ 30% EBITDA

Potential revenue from Tier 1 deployment alone
(airports, seaports & border control globally)

No Wait. No Lab. No Delay.

Unlike PCR or lateral flow, ViruSense returns results in real time — enabling immediate isolation, alert, and response before viral spread occurs.

100× Smaller Than a Virus

NPL-verified technology already detects molecular compounds 100 times smaller than virus particles. Virus detection is a natural extension, not a leap of faith.

The next pandemic is coming. Will you be ready?
Enquire about ViruSense: nanosense.com